Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Exploratory Study to Evaluate the Safety and Tolerability of Tamoxifen Citrate in the Treatment of Cystic Fibrosis in Patients Without Mutations Currently Eligible for Therapy With CFTR Modulator Drugs

NCT07289035 is registered in ClinicalTrials.gov with Azienda Ospedaliera Universitaria Integrata Verona as lead sponsor.

NCT NCT07289035
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07289035 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Exploratory Study to Evaluate the Safety and Tolerability of Tamoxifen Citrate in the Treatment of Cystic Fibrosis in Patients Without Mutations Currently Eligible for Therapy With CFTR Modulator Drugs
Lead sponsor
Azienda Ospedaliera Universitaria Integrata Verona
Phase
Phase 2
Overall status
Not yet recruiting
Start date
January 15, 2026
Completion date
February 1, 2027
Enrollment
35 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cystic fibrosis - complete